<p>Galectin Therapeutics Inc. has approved cash retention bonuses for two of its top executives. Chief Medical Officer Dr. Khurram Jamil will receive a $300,000 bonus, while Chief Financial Officer Jack Callicutt will receive $150,000. Each bonus will be paid in three equal installments on June 1, September 1, and December 1, 2026. The bonuses must be repaid if the officers resign without good reason or are terminated for cause before December 31, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galectin Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-001866), on January 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</p>

Reuters

iShares Biotechnology ETF

Health Care Select Sector SPDR

VG Health

ALPS Medical Breakthrough

Direxion S&P Biotech Bear 3X

SPDR S&P Biotech

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

Invesco Nasdaq Biotechnology ETF

Ark Genomic Revolution ETF

Galectin Therap

Proshares Ultra Nasdaq Biotech

First Trust NYSE Arca Biotech Index Fd

iShares US Pharma

Galectin Therapeutics Awards Retention Bonuses to Chief Medical and Financial Officers